Prollenium Medical Technologies is a Canadian-based, privately owned manufacturer and distributor of premium hyaluronic acid dermal fillers, and the only HA dermal filler manufacturer in North America. Founded in 2002, Prollenium developed the Revanesse® line of fillers using advanced cross-linking technology, achieving FDA, Health Canada, and CE approvals with over 5.5 million syringes sold in 80+ countries. Their commitment to in-house research, manufacturing, and rigorous quality standards makes Revanesse one of the fastest-growing filler brands globally.